Latest news with #mergersandacquisitions
Bloomberg
4 hours ago
- Business
- Bloomberg
CPE Is Said to Near Sale of Haircare Chain Hairology to Kidswant
Beijing-based private equity firm CPE is close to finalizing an agreement to sell hair treatment chain Zhuhai Hairology Spa Corp. to Kidswant Children Products Co., according to people familiar with the situation. Kidswant emerged as the frontrunner in a bidding process for the Chinese firm, the people said, asking not to be identified discussing a private matter. A sale of Hairology could fetch between $200 million and $300 million, they said, adding that an agreement could be announced as soon as the coming days.
Hospitality Net
3 days ago
- Business
- Hospitality Net
Dalata Draws a Line in the Sand, Spurning Pandox's 'Low-Ball' Bid
In a firm show of resolve, Dalata Hotel Group has slammed the door on an unsolicited €6.05-per-share cash approach from the Pandox–Eiendomsspar partnership, branding the proposal a glaring undervaluation of Ireland's largest hotel operator. Dalata's board—already running a formal sales process (FSP) as part of a broader strategic review—wasted little time before issuing a unanimous rejection. Even in the notoriously polite world of deal announcements, the subtext was unmistakable: thanks, but no thanks—come back when you understand our worth. Why the snub? At first glance, a headline price of 605 cents might look generous; it represents a tidy premium to where the shares traded before rumours of a sale began swirling in March. But Dalata's directors have done the maths. The group controls 53 hotels, a well-oiled development pipeline, and a balance sheet that weathered the pandemic better than many peers. With Irish and UK occupancy snapping back to record levels and RevPAR still climbing, management believes value will only fatten from here. More crucially, the Pandox consortium declined to join the board-run sales process—an early sign, Dalata feels, that the Swedish-Norwegian duo were unwilling to meet the same disclosure and timetable obligations demanded of other bidders. By ducking the data-room drill, Pandox forfeited its opportunity to sharpen the pencil. Clock is ticking for Pandox Under Irish Takeover Rule 2.6, the consortium now has until 5 p.m. (Dublin), 15 July to 'put up or shut up': either table a binding Rule 2.7 offer or announce it is walking away for at least six months. The Takeover Panel rarely grants extensions without compelling cause, so the midsummer deadline is real. What next for shareholders? For the moment, Dalata urges investors to sit tight. Several unnamed suitors remain inside the FSP's tent, each having fired in a non-binding proposal. If any sees strategic or synergistic sparkle that Pandox overlooked, a bidding contest could still break out. Yet nothing is guaranteed. Prospective buyers may balk at the very valuation uplift Dalata is chasing. And while trading momentum is strong, the hotel cycle can turn as swiftly as it recovers; the board's definition of 'full value' may prove elusive if financing costs creep higher through 2025. Still, yesterday's brusque rebuttal sends a clear message: Dalata believes it controls its own destiny—and won't relinquish it cheaply. Pandox must now decide whether to dig deeper or bow out. Either way, the coming six weeks promise to test convictions on both sides of the negotiating table. Read the full article at
Associated Press
27-05-2025
- Business
- Associated Press
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates INZY, TXNM, SVT, PTIX on Behalf of Shareholders
NEW YORK, May 27, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Inozyme Pharma, Inc. (NASDAQ: INZY)'s sale to BioMarin Pharmaceutical Inc. for $4.00 per share. If you are an Inozyme shareholder, click here to learn more about your rights and options . TXNM Energy, Inc. (NYSE: TXNM)'s sale to Blackstone for $61.25 per share in cash. If you are a TXNM shareholder, click here to learn more about your legal rights and options . Servotronics, Inc. (NYSE: SVT)'s sale to TransDigm Group Incorporated for $38.50 per share in cash. If you are a Servotronics shareholder, click here to learn more about your rights and options . Protagenic Therapeutics, Inc. (NASDAQ: PTIX)'s merger with Phytanix Bio Inc. Upon completion of the proposed transaction, Protagenic shareholders are expected to own approximately 35% of the combined company. If you are a Protagenic shareholder, click here to learn more about your rights and options . Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders. We would handle the action on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses. Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email [email protected] or [email protected] . Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors. Attorney Advertising. Prior results do not guarantee a similar outcome. Contact Information: Halper Sadeh LLC Daniel Sadeh, Esq. Zachary Halper, Esq. One World Trade Center 85th Floor New York, NY 10007 (212) 763-0060 [email protected] [email protected]
Times
21-05-2025
- Business
- Times
Engineering firm Renold targeted by private equity pair
A 161-year-old British manufacturer of industrial chains and clutches is being circled by private equity firms hoping to take it out in a deal worth over £160 million. Renold, based in Manchester, has in recent weeks received 'several' proposals from two parties. One is a consortium comprising Buckthorn Partners, a London private equity firm, along with One Equity Partners from New York. The other is from Webster Industries, an American rival owned by Morgenthaler Private Equity. Neither suitor has made a formal offer yet, although Buckthorn and One Equity have said they are considering bidding 81p for each Renold share, which would value the business at about £162 million. Webster's latest proposal is at a price of 77p for each Renold share, which equates to
Yahoo
19-05-2025
- Business
- Yahoo
Archer Ltd (ARHVF) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ...
Release Date: May 15, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Archer Ltd (ARHVF) has announced the initiation of dividend payments, starting with $5.5 million for Q2, reflecting strong cash flow and financial health. The company has achieved significant growth, with a 24% increase in revenue since 2022, driven by both organic growth and mergers and acquisitions. Archer Ltd (ARHVF) has successfully refinanced with a new $425 million secured bond, providing financial stability and a lower leverage ratio. The company has secured several large contracts, enhancing visibility and deepening customer relationships, particularly in well services and platform operations. Archer Ltd (ARHVF) is expanding into renewable services, generating over $100 million in revenue with a 10% margin, and is cash positive in this segment. The company is experiencing a reduction in revenue guidance due to decreased activity in Argentina, impacting approximately 5% of global revenue. Archer Ltd (ARHVF) is undergoing restructuring in Argentina, resulting in a reduction of 500 employees and a $75 million annual revenue decrease. Working capital has seen an unfavorable development in Q1, with accounts receivable days outstanding increasing from 47 to 52 days. There are uncertainties regarding the timing and accounting of one-off expenses related to restructuring in Argentina, which may continue into Q2. The company faces challenges in maintaining cash flow from Argentina due to ongoing restructuring and investment in new growth areas. Warning! GuruFocus has detected 2 Warning Signs with ARHVF. Q: Can you explain the unfavorable development in working capital during Q1 2025? A: The increase in working capital is mainly due to accounts receivable, which rose from 47 days outstanding in Q4 to 52 days in Q1, aligning with our normal range. Additionally, we invested in inventory items for growth in international services. These factors contributed to the increased working capital. - CFO Q: What is the outlook for 2026 based on the current visibility for 2025? A: While 2026 seems distant, we have a good backlog and visibility that suggests continuity into next year. Q1 typically has fewer days, affecting the run rate, but we expect to return to a new run rate by Q2 and Q3. - CEO Q: Will there be more one-off items related to Argentina in the upcoming quarters? A: Yes, there will be some one-off items in Q2 as we finalize restructuring in Argentina. The accounting details are still being worked out, but we expect some exceptions on both the negative and positive sides. However, these will not impact cash flow significantly as we are selling some assets to fund these changes. - CEO Q: Why was the revenue guidance lowered while the EBITDA guidance was maintained? A: The revenue reduction is largely due to Argentina, where margins are low. The mix of product sales and reduced reimbursables, which have zero margins, also contributed. The revenue loss is marginal and does not affect our core services or product sales. - CEO Q: What impact will the two FLNG vessels in Argentina have on drilling demand in Vaca Muerta? A: We anticipate a doubling of the rig count by 2030, with 10 to 15 additional rigs between 2026 and 2027. The construction of pipelines will drive this demand, as oil companies will need to fill them. The timing will depend on cash flow and global oil prices. - CEO For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus. Sign in to access your portfolio
